variant classification
PGDx, Qiagen Partner on Clinical Decision Support for Molecular Cancer Testing
Laboratories that purchase PGDx Elio genomic profiling tests will receive access to Qiagen's QCI Interpret One for rapid, evidence-based variant interpretation.
Illumina, PierianDx Expand Partnership on Cancer Panel Test Reporting
The deal builds on a non-exclusive partnership signed in January 2019 and PierianDx will now support three more Illumina cancer sequencing assays.
Invitae Acquires Three Companies: YouScript, Genelex, Diploid
Invitae said YouScript and Genelex will enable it to provide pharmacogenomic testing, while Diploid will help interpret WGS results.
Quest Files Motion for Summary Judgment in Wrongful Death Lawsuit
Following a lengthy discovery period, the lab is asking a South Carolina federal district court to find in its favor and decide that its negligence did not result in the death of Williams' son.
In seven years, the public variant classification database has steadily become a resource that labs are submitting to and that genetics experts are consulting.